Much is known about how HIV evolves and adapts to the human immune system during untreated infection, but in order to one day find a vaccine or cure, more knowledge is needed about the landscape of viruses lying dormant in the bodies of infected people, even when strictly adhering to antiretroviral therapy.
The 28th Annual Canadian Conference on HIV/AIDS Research is the premier gathering in Canada for those working in all disciplines of HIV/AIDS research, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. The conference, also known as CAHR 2019, will be held May 9th-12th, 2019.
BC-CfE research presented at the CAHR 2019 conference Read More »
In addition to leading a number of ancillary events, researchers from the BC-CfE presented important findings at this year’s CAHR Conference in Saskatoon-including several Peer Research Associates offering a community perspective. The 28th Annual Canadian Conference on HIV/AIDS Research is the premier gathering in Canada for those working in all disciplines of HIV/AIDS research, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.
Highlights: BC-CfE Research at CAHR 2019 in Saskatoon! Read More »
There is a generation gap when it comes to knowing and understanding HIV prevention. Young gay and bisexual men and other men who have sex with men (YGBM) in BC are less likely to be aware of some HIV prevention and treatment options compared to older men, according to a recently published BC-CfE study.
Education key to HIV awareness among youth Read More »
In April, the BC-CfE was honoured to host Dr. Steffanie Strathdee, Associate Dean of Global Health Sciences at the University of California, San Diego, to share her enthralling account of saving her own husband from a superbug-a bacteria pan-resistant to antibiotic treatment.
HIV researcher turned “Superbug Slayer” visits the BC-CfE Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
